Journal
Journal of Allergy and Clinical Immunology: In Practice
Publication Date
7-24-2019
Volume
8
Issue
2
First Page
527
Last Page
539.e9
Document Type
Open Access Publication
DOI
10.1016/j.jaip.2019.07.016
Rights and Permissions
Maspero JF, Katelaris CH, Busse WW, Castro M, Corren J, Chipps BE, Peters AT, Pavord ID, Ford LB, Sher L, Rabe KF, Rice MS, Rowe P, Lu Y, Harel S, Jagerschmidt A, Khan AH, Kamat S, Pirozzi G, Amin N, Ruddy M, Graham NMH, Mannent LP, Teper A. (2019) Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis. J Allergy Clin Immunol Pract, 8(2): 527-539.e9. doi: 10.1016/j.jaip.2019.07.016. Copyright 2019 The Authors. Published by Elsevier Inc. on behalf of the American Academyof Allergy, Asthma & Immunology. This is an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).https://doi.org/10.1016/j.jaip.2019.07.016J ALLERGY CLIN IMMUNOL PRACTFEBRUARY 2020528MASPERO ETAL
Recommended Citation
Maspero, Jorge F; Castro, Mario; and et al, "Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis." Journal of Allergy and Clinical Immunology: In Practice. 8, 2. 527 - 539.e9. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8757
